Context Therapeutics Inc.

NASDAQ: CNTX · Real-Time Price · USD
0.73
0.03 (4.29%)
At close: Aug 14, 2025, 3:52 PM
0.75
2.75%
After-hours: Aug 14, 2025, 07:58 PM EDT

Context Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a -12.04K -9.27K n/a
Operating Income
-29.92M -25.07M -15.38M -10.53M
Interest Income
3.2M 1.16M 547.27K 64.24
Pretax Income
-26.73M -23.96M -14.84M -10.46M
Net Income
-26.73M -23.96M -14.84M -10.46M
Selling & General & Admin
7.22M 7.29M 7.79M 3.63M
Research & Development
22.7M 17.78M 7.09M 3.81M
Other Expenses
n/a n/a -2K n/a
Operating Expenses
29.92M 25.07M 14.88M 7.44M
Interest Expense
n/a n/a 547.27K 64.24K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
29.92M 25.07M 14.88M 7.44M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
58.42M 15.97M 15.97M 2.83M
Shares Outstanding (Diluted)
58.42M 15.97M 15.97M 2.83M
EPS (Basic)
-0.46 -1.5 -0.93 -3.69
EPS (Diluted)
-0.46 -1.5 -0.93 -3.69
EBITDA
-26.67M -25.06M -14.83M -10.53M
EBIT
-26.73M -25.07M -14.84M -7.44M
Depreciation & Amortization
52.7K 12.04K 9.27K -3.09M